Ruxolitinib 5mg Tablet – Imported | Long Product Description

Product Overview

Ruxolitinib 5mg Tablet – Imported is a prescription medicine containing ruxolitinib, a Janus kinase (JAK) inhibitor. It works by blocking specific signalling pathways involved in blood-cell production and immune-system activity.

Ruxolitinib may be prescribed for certain blood disorders, including myelofibrosis, and for selected cases of polycythaemia vera and graft-versus-host disease, depending on the patient’s condition and the applicable treatment guidelines.

This product listing specifies Lucius Pharmaceuticals as the manufacturer and a pack size of 60 tablets. Ruxolitinib requires specialist supervision and regular monitoring. The manufacturer’s details and pack information should be checked against the original packaging before purchase.

Key Product Information

• Product Name: Ruxolitinib 5mg Tablet
• Generic Name: Ruxolitinib
• Strength: 5mg
• Dosage Form: Tablet
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 60 Tablets
• Product Type: Imported Medicine
• Drug Class: Janus Kinase (JAK) Inhibitor
• Therapeutic Category: Targeted Therapy
• Availability: Contact MedicineWalyDost.com to confirm current stock and prescription requirements.

Uses of Ruxolitinib 5mg Tablet

1. Myelofibrosis

Myelofibrosis is a bone marrow disorder that affects normal blood-cell production. It may cause fatigue, weakness, an enlarged spleen, and abdominal discomfort. Ruxolitinib may help manage symptoms and reduce spleen enlargement in eligible patients.

2. Polycythaemia Vera

Polycythaemia vera is a condition in which the body produces too many red blood cells. Ruxolitinib may be prescribed to adults who have not responded adequately to hydroxyurea or cannot tolerate it.

3. Graft-versus-Host Disease (GvHD)

Graft-versus-host disease can develop after certain stem-cell transplants when donor immune cells attack the recipient’s tissues. Ruxolitinib may be used for specific forms of acute or chronic GvHD when clinically appropriate.

Important: Approved uses vary by country and product. A qualified specialist must determine whether ruxolitinib is appropriate for the patient’s diagnosis.

How Does Ruxolitinib Work?

Ruxolitinib inhibits Janus kinase enzymes, particularly JAK1 and JAK2. These enzymes help transmit signals involved in blood-cell production and immune responses.

By reducing these signals, ruxolitinib can help manage abnormal signalling associated with certain bone marrow disorders and immune-related complications. The benefits and response to treatment vary from patient to patient.

Dosage and How to Take Ruxolitinib 5mg Tablet

Ruxolitinib should be taken exactly as prescribed by the treating specialist.

• Follow the prescribed dose and schedule.
• Take the tablet according to the instructions provided with the verified product.
• Do not change the dose or stop treatment without consulting your doctor.
• If you miss a dose, follow the patient leaflet or ask your healthcare professional what to do. Do not take an extra dose to make up for a missed one.
• Attend all recommended appointments and blood tests.
• Tell your doctor about all prescription medicines, over-the-counter medicines, and supplements you take.

Important dosage information: A 5mg tablet does not mean that every patient should take 5mg per dose. The prescribed regimen depends on the condition being treated, blood counts, liver and kidney function, other medicines, and treatment response. For some patients with myelofibrosis or graft-versus-host disease, 5mg twice daily may be used as an initial regimen under specific circumstances. This is not a personal dosing recommendation.

Possible Side Effects

Ruxolitinib can cause side effects. Not everyone experiences them, and some effects require medical attention.

Possible side effects include:

• Anaemia or reduced red blood cell counts
• Low platelet counts
• Low white blood cell counts
• Bruising or bleeding
• Dizziness
• Headache
• Fatigue or weakness
• Increased risk of infections
• Changes in cholesterol or other laboratory results

Serious Side Effects and Risks

Infections: Ruxolitinib can increase the risk of serious infections. Contact your healthcare professional promptly if you develop fever, chills, a persistent cough, or other signs of infection.

Low blood counts: Anaemia, thrombocytopenia, and neutropenia may occur. Regular blood tests help your doctor monitor these risks.

Bleeding: Low platelet counts may increase bleeding risk. Seek urgent medical care for severe bleeding, black stools, or blood in the urine.

Skin changes: Non-melanoma skin cancers have been reported. Your doctor may recommend periodic skin examinations.

Blood clots and cardiovascular problems: Seek urgent medical attention for chest pain, sudden shortness of breath, one-sided leg swelling, or sudden weakness.

Symptoms after stopping treatment: Symptoms of the underlying condition may worsen after treatment interruption or discontinuation. Do not stop taking ruxolitinib without medical advice.

Precautions and Warnings

Before starting Ruxolitinib 5mg Tablet, tell your doctor about your medical history and current treatments.

Infection Screening

Your doctor may check for tuberculosis and other infections before treatment. Existing serious infections may need to be addressed before therapy begins.

Blood Test Monitoring

Blood counts should be checked before and during treatment. Your doctor may change or interrupt the prescribed dose depending on the results.

Liver and Kidney Conditions

Tell your doctor if you have liver or kidney problems, as these may affect treatment suitability or dosing.

Pregnancy and Breastfeeding

Discuss pregnancy, contraception, and breastfeeding with your healthcare professional before using ruxolitinib. Follow the precautions in the official product information.

Other Medical Conditions

Tell your doctor if you have a history of cancer, blood clots, cardiovascular disease, or recurrent infections. Your specialist can assess your individual risks.

Drug Interactions

Some medicines can affect ruxolitinib levels in the body and increase the risk of side effects.

Tell your doctor or pharmacist if you use:

• Certain antifungal medicines
• Some antibiotics
• Certain antiviral medicines
• Other medicines that suppress immune activity
• Herbal products or dietary supplements

Do not start, stop, or combine medicines without professional advice. Your doctor or pharmacist should review your full medication list.

Who Should Use Ruxolitinib 5mg Tablet?

Ruxolitinib may be prescribed for patients with particular conditions for which the medicine is indicated, including certain cases of myelofibrosis, polycythaemia vera, or graft-versus-host disease.

It is not suitable for self-medication. A specialist must assess the diagnosis, blood counts, infection risks, other medical conditions, and current medicines before prescribing it.

Storage Instructions

• Follow the storage instructions on the original packaging.
• Keep the tablets in their original packaging when appropriate.
• Protect the medicine from unsuitable temperatures and moisture.
• Keep it out of the reach of children and pets.
• Do not use the medicine after its expiry date or if the packaging appears damaged.

Why Choose MedicineWalyDost.com?

MedicineWalyDost.com helps customers explore imported medicines and review product information before making an enquiry.

For Ruxolitinib 5mg Tablet – Imported, contact MedicineWalyDost.com to confirm the current price, availability, pack size, manufacturer details, prescription requirements, and delivery options.

Always verify the medicine and its original packaging before purchase. Prescription medicines should be obtained through an appropriately authorised pharmacy and used under specialist supervision.

Frequently Asked Questions (FAQs)

1. What is Ruxolitinib 5mg Tablet used for?

Ruxolitinib may be prescribed for certain blood disorders, including myelofibrosis and eligible cases of polycythaemia vera, as well as selected forms of graft-versus-host disease.

2. How does ruxolitinib work?

It blocks JAK1 and JAK2 enzymes involved in signalling pathways that regulate blood-cell production and immune activity.

3. Who is the manufacturer of this product?

The manufacturer provided for this listing is Lucius Pharmaceuticals. Please verify the manufacturer against the original product packaging.

4. What is the pack size?

The product details provided specify a pack size of 60 tablets.

5. Is 5mg the correct dose for every patient?

No. The dose depends on the condition being treated, blood test results, other medical conditions, and treatment response. Take it only as prescribed.

6. What are the possible side effects?

Possible side effects include anaemia, low platelet counts, low white blood cell counts, bruising, dizziness, headache, and increased susceptibility to infections.

7. Does ruxolitinib require blood tests?

Yes. Regular blood tests are important to monitor blood-cell counts and help the treating specialist assess safety.

8. How can I check availability in Pakistan?

Contact MedicineWalyDost.com to confirm current availability, price, prescription requirements, and delivery details.

Contact MedicineWalyDost.com Today

Looking for Ruxolitinib 5mg Tablet – Imported? Contact MedicineWalyDost.com to confirm the current price, availability, prescription requirements, and delivery details.

Use this medicine only under the supervision of a qualified healthcare professional.